Ezetimibe and cancer - An uncertain association

New England Journal of Medicine

Volumn 359, Issue 13, 2008, Pages 1398-1399

  Drazen, Jeffrey M ^a   D'Agostino, Ralph B ^a   Ware, James H ^a   Morrissey, Stephen ^a   Curfman, Gregory D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; PLACEBO; SIMVASTATIN;

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; CANCER RISK; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DIGESTIVE SYSTEM CANCER; DRUG INDUCED CANCER; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEART PROTECTION; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROSTATE CANCER; RENAL PROTECTION; SKIN CANCER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 52649154169     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0807200     Document Type: Editorial

References (2)

1. Rossebø AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-56.
2. Peto R, Emberson J, Landray M, et al. Analyses of cancer data from three ezetimibe trials. N Engl J Med 2008;359:1357-66.